Yutao Liu from Georgia Regents University: Delaying the Progression of Glaucoma
May 5th 2016Yutao Liu, MD, PhD, Georgia Regents University, discussed how he and his team can potentially target genes to either reduce glaucoma or provide neuroprotection specifically for the mitochondria in the retina.
Read More
According to Henry Kaplan, MD, University of Louisville School of Medicine, "One has to recognize that there are multiple approaches like gene therapy, neuroprotection, stem cell transplantation, and pharmacologic manipulation of other genes really holds the greatest benefit in terms of trying to reverse the inevitable loss of vision."
Read More
Henry Kaplan from University of Louisville School of Medicine: The Immunology of the Eye
May 5th 2016Henry Kaplan, MD, KY Lions Eye Center, University of Louisville School of Medicine, is focusing his efforts on figuring out how to preserve or recover lost central vision in patients with retinitis pigmentosa.
Read More
Andrew Hartwick from The Ohio State University: TBI Bursting Into Public Attention
May 3rd 2016Andrew Hartwick, PhD, The College of Optometry at The Ohio State University wants to understand why regardless of normal, standard vision tests, there is still clearly something wrong with pateints' sight.
Read More
Andrew Hartwick from The Ohio State University: Photophobia in Traumatic Brain Injury Patients
May 2nd 2016Andrew Hartwick, PhD, Associate Professor at The College of Optometry at The Ohio State University discussed his research surrounding traumatic brain injury (TBI) patients who experience increased light sensitivity, or photophobia.
Read More
For Robin Williams, Diagnosis Came Too Late
April 19th 2016Susan Schneider Williams, spouse of the late Robin Williams spoke with MD Magazine about the several symptoms the actor presented up to a year before his death that made it difficult to diagnose what he was suffering from: Lewy Body Disease (LBD).
Read More
Further Analysis of the Benefits of Deflazacort in Patients with Duchenne Muscular Dystrophy
April 19th 2016Researchers at the American Academy of Neurology’s 68th Annual Meeting reported analyses of the phase III trial of the investigational glucocorticoid (deflazacort/Marathon Pharmaceuticals), which was previously found to improve muscle strength in Duchenne Muscular Dystrophy (DMD) patients.
Read More
Fycompa: Effective Treatment for Primary Generalized Tonic-Clonic Seizures
April 18th 2016Treating patients suffering from primary generalized tonic-clonic (PGTC) seizures with once-daily 8mg doses of adjunctive perampanel (Fycompa/Eisai) can effectively control the seizures, recent study finds.
Read More
Researchers Recommend Low-Dose Aspirin for High-Risk Cardiovascular and Colon Cancer Patients
April 12th 2016Low-dose aspirin intake can benefit adult patients who exhibit a high risk for both cardiovascular-related events and colorectal cancer, reported the US Preventive Services Task Force (USPSTF).
Read More